Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

WHAT'S NEW

  • RFK Jr.
  • Hantavirus Outbreak
  • AI in Healthcare
  • Makary Resigns
  • Pancreatic Cancer Drug

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Nov 16 2023

Full Issue

Biden, Xi Agree To Crack Down On Fentanyl Production

President Joe Biden said Chinese leader Xi Jinping on Wednesday agreed to take steps to curb companies in China that produce chemicals used in the production of fentanyl that is eventually exported to the U.S.

AP: Biden And China's Xi Agree To Curb Illicit Fentanyl

U.S. President Joe Biden and China’s Xi Jinping emerged Wednesday from their first face-to-face meeting in a year vowing to stabilize their fraught relationship and showcasing modest agreements to combat illegal fentanyl and re-establish military communications. But there were still deep differences on economic competition and global security threats. (Madhani, Long, and Tang, 11/16)

Axios: Biden And Xi Agree To Curb Fentanyl Production

The agreement is aimed at limiting the manufacturing and export of fentanyl precursor molecules from China to Mexico, where much of the synthetic opioid in the U.S. now originates. In 2019, China banned the production sale and export of all fentanyl-related drugs in most circumstances, but that simply shifted the supply chain around. Cooperation on fentanyl has previously become entangled in broader geopolitical tensions. Last year, for example, China suspended cooperation with the U.S. on the issue to protest then-House Speaker Nancy Pelosi's trip to Taiwan. (Owens and Snyder, 11/15)

San Francisco Chronicle: Xi Says China ‘Sympathizes Deeply’ With Americans Over Fentanyl Crisis

Chinese President Xi Jinping, speaking at the Hyatt Regency in downtown San Francisco, said a fentanyl deal between China and the United States would help crack down on the manufacturing and export of the deadly opioid that is devastating San Francisco and the rest of the U.S. “I would like to let you know that China sympathizes deeply with the American people, especially the young, for the sufferings that fentanyl has inflicted upon them. President Biden and I have agreed to set up a working group on counternarcotics to further our cooperation and help the United States tackle drug abuse,” Xi said. (Toledo, Li, Mishanec, Ravani and Munce, 11/15)

Reuters: Italy Arrests Six In Crackdown On Fentanyl Smuggling From China To U.S. 

Italian police have arrested six people in a crackdown on a network that allegedly played go-between for fentanyl trafficking from China to the United States, Guardia di Finanza police and prosecutors in the northern city of Piacenza said on Wednesday. (Parodi, 11/15)

In other news about the opioid crisis —

San Francisco Chronicle: SF Drug Overdose Deaths So Far Already Exceed Totals From Last Year

San Francisco is on track to see the deadliest year on record for accidental drug overdose deaths in 2023, newly released preliminary data from the medical examiner's office shows. Between January and October, the city recorded 692 deaths — already higher than last year's total of 649, and 642 from the year before. If the city continues its average pace of 69 deaths per month, it will close out the year with a total of 830 deaths. That’s 28% higher than last year’s total, and 14% higher than the previous peak of 726 deaths in 2020. (Leonard, 11/15)

Stat: Tiny Wisconsin Tribe Becomes Model For Opioid Harm Reduction

Sunlight is streaming through holes in the walls of a disused, corrugated metal shack, revealing its modest insides: Dirt floors, stacks of two-by-fours, and a pile of Little Caesars pizza boxes under attack by a work crew on lunch break. This building is clearly not ready to be a home. But in the next 24 hours, it must become one. At this time of year, sleeping outdoors is deadly. And barely 100 yards away, on the historic pow-wow grounds of the Bad River Tribe, stands a small tent city still thawing out from yesterday’s first snow. Its inhabitants, left homeless by addiction to fentanyl and methamphetamine, have nowhere else to go. (Facher, 11/16)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF